Concerto Biosciences, Inc.

Biotechnology company · Allston, Massachusetts, United States

Concerto Biosciences, Inc. is a biotechnology company headquartered in Allston, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $299,907 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Concerto Biosciences at a glance

Typebiotechnology company
HeadquartersAllston, Massachusetts, United States
Earliest incorporation on record2020
SEC CIK1918491

What does Concerto Biosciences do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $299,907 in total (2022). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $24.5 million sold (2022).

Frequently asked questions about Concerto Biosciences

Where is Concerto Biosciences headquartered?

Concerto Biosciences, Inc. is headquartered in Allston, Massachusetts, United States.

What does Concerto Biosciences do?

Concerto Biosciences, Inc. is a biotechnology company.

When was Concerto Biosciences founded?

The earliest incorporation on record for Concerto Biosciences, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.